Background Anaemia is a common problem experienced by critically‐ill people. Treatment
with erythropoiesis‐stimulating agents (ESAs) has been used as a pharmacologic strategy …

Myocardial infarction (MI) is a global cause of morbidity and mortality. MI is the outcome of a
chronic process termed atherosclerosis, a buildup of fatty and other substances called …

Introduction The principal voltage-gated Na+ channel, Na V 1.5 governs heart excitability
and conduction. Na V 1.5 dysregulation is responsible for ventricular arrhythmias and …

Background/Aims: Hypertension is the leading cause of death worldwide. Chronic high
blood pressure induces inflammation. Tumor necrosis factor (TNF)-α plays a major role in …

Cardiac abnormalities and dysfunction are the most important complications after renal
ischemia-reperfusion (IR). Thus, investigation and development of effective treatment to …

: Erythropoietin (Epo) is the main erythropoiesis hormone, activate the progenitor red blood
cells through proliferation, differentiation and maturation of red blood cells. However, it's …

In addition to the long-established role in erythropoiesis, erythropoietin (Epo) has protective
functions in a variety of tissues, including the heart. This is the most affected organ in chronic …

Creatine kinase isoenzyme (CK-MB) is a cardiac biomarker for post-PCI recovery
evaluation. This work describes a novel biosensor concept that can be used to quantify …

Аннотация Острый инфаркт миокарда (ОИМ) является одной из главных причин
смертности трудоспособного населения в России и населения экономически развитых …

Myocardial infarction (MI) is a leading cause of death globally. Over 3 million individuals
experience ST-segment elevation MI (STEMI) each year. Despite considerable research into …